The T cell in Sjogren's syndrome: force majeure, not spectateur.
about
Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosisReviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatmentElevated Plasma P-Selectin Autoantibodies in Primary Sjögren Syndrome Patients with ThrombocytopeniaFunctional Analysis of Dendritic Cells Generated from T-iPSCs from CD4+ T Cell Clones of Sjögren's Syndrome.The cytokine TGF-β co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cellsReduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.Novel aspects of Sjögren's syndrome in 2012.Efficacy and safety of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis: rheumatoid arthritis with orencia trial toward Sjögren's syndrome Endocrinopathy (ROSE) trial-an open-label, one-year, prospective study-InteUse of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory DiseasesIL-17 sequestration via salivary gland gene therapy in a mouse model of Sjogren's syndrome suppresses disease-associated expression of the putative autoantigen Klk1b22A chimeric human-mouse model of Sjögren's syndrome.eFORGE: A Tool for Identifying Cell Type-Specific Signal in Epigenomic Data.Effect of Tobacco Smoking on The Clinical, Histopathological, and Serological Manifestations of Sjögren's Syndrome.The status of glucocorticoid-induced leucine zipper protein in the salivary glands in Sjögren's syndrome: predictive and prognostic potentials.T Cell-Associated Cytokines in the Pathogenesis of Sjögren's SyndromeThe immune factors involved in the pathogenesis, diagnosis, and treatment of Sjogren's syndromeEndogenous programmed death ligand-1 restrains the development and onset of Sjӧgren's syndrome in non-obese diabetic mice.Persistence and selection of an expanded B-cell clone in the setting of rituximab therapy for Sjögren's syndrome.Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.Pathogenic role of endogenous TNF-α in the development of Sjögren's-like sialadenitis and secretory dysfunction in non-obese diabetic mice.Less travelled roads in clinical immunology and allergy: drug reactions and the environmental influence.Th17 cells in autoimmune diseases.Is it Sjögren's syndrome or burning mouth syndrome? Distinct pathoses with similar oral symptoms.Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases?Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome.Cutaneous and Mucosal Manifestations of Sjögren's Syndrome.Upregulation of long noncoding RNA TMEVPG1 enhances T helper type 1 cell response in patients with Sjögren syndrome.CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sjögren syndrome.The potential relationship between Flammer and Sjögren syndromes: the chime of dysfunction.Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab).Anti-IL-7 receptor-α treatment ameliorates newly established Sjögren's-like exocrinopathy in non-obese diabetic mice.Mesenchymal Stem Cells in Primary Sjögren's Syndrome: Prospective and Challenges
P2860
Q28533202-AAB20A26-A084-448E-AA10-157A5B2D5342Q30234992-FA51C790-19D0-49A9-ABF2-2EA4A3071210Q33427935-303589C2-A1E1-4D19-A3FD-6D7A8D0C2B64Q33659579-1BD0C1C3-5CB0-4956-BADB-45848D7D0761Q34280534-D7EEAE97-0C6D-42B7-90B1-D6D2840E7495Q34473302-70BA7E52-27BE-4541-80D1-C318CE3B3155Q34650103-E4F7D59C-E742-4EB4-BB81-E9E06DFCEE65Q35318424-D234154B-6034-4FD4-A504-2C9ED1369A4DQ35738486-155CF927-0329-43BC-B02C-32E76A83BF3DQ35923212-82407A2F-8C68-415A-B0B0-E044C0CED420Q36150667-EF7C8D4F-7BFE-4A0F-B164-6000EEEB0D12Q36194281-5E9FBB44-683A-4112-A2CB-08006C543D2CQ36271895-27F5B141-4A9B-4E59-B33F-316D8236733AQ36549665-DED637FB-C67F-4C1B-92E3-852A9A185B71Q36957148-6D6505DA-BDE5-4D80-9F4B-13FD6E3A9288Q37044113-F6A79F6C-3D6C-491D-9B1A-4FCB09DFDEDBQ37501812-90A6588A-19A5-4B8F-98A4-B0BD60A07657Q37690012-DF12756F-E20A-4FE9-AE30-EA7FE0C15857Q37696996-74ED4292-8897-45E8-9D48-F3D3856257C6Q37733323-4DFCE738-D8C2-4333-97F9-D1FA1A56B4AAQ38120660-DD4F94FD-C8A3-47F6-ACD0-E455C1FB2071Q38344543-87F137F2-6370-49B6-9A24-97B92355EB32Q39173291-95DC1CA4-1ACC-4644-B1E6-9C591120EC19Q39285168-BCEEEDF5-B0A4-48F5-82B1-66B244D9AEECQ39418862-C756A373-C83C-4B43-A099-B51CF1881EA3Q40067064-7CE0C991-C56C-4148-A3F4-DDEFE89CD2EAQ40462144-B45C347A-7DCE-4492-AB8C-93A5E4272C31Q42743849-566A3356-6DAB-41DB-AABA-ABD4A19D2A22Q47098371-37C8A151-D361-402B-9601-AADFB3BC054FQ51075376-4A49E213-7965-440A-A04C-AEC36BD951EAQ52572230-99DC4AE0-E351-47B4-8611-50770053E670Q57300327-C8760122-2250-46E1-A987-4FF82059DC93
P2860
The T cell in Sjogren's syndrome: force majeure, not spectateur.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The T cell in Sjogren's syndrome: force majeure, not spectateur.
@en
type
label
The T cell in Sjogren's syndrome: force majeure, not spectateur.
@en
prefLabel
The T cell in Sjogren's syndrome: force majeure, not spectateur.
@en
P2860
P1476
The T cell in Sjogren's syndrome: force majeure, not spectateur
@en
P2093
Philip L Cohen
P2860
P304
P356
10.1016/J.JAUT.2012.05.019
P577
2012-06-17T00:00:00Z